14.05USD
3.62 BUSD
9.84 BUSD
257.54 M
About VERTEX PHARMACEUTICAL COM STK USD0.01
Sector
CEO
Reshma Kewalramani
Headquarters
Boston
Website
Employees (FY)
5.4 K
Founded
1989
FIGI
BBG00JRYC2N1
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 0QZU is featured.
Frequently Asked Questions
The current price of 0QZU is 404.80 USD — it has increased by 0.19% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange VERTEX PHARMACEUTICAL COM STK USD0.01 stocks are traded under the ticker 0QZU.
VERTEX PHARMACEUTICAL COM STK USD0.01 is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
0QZU stock is 0.81% volatile and has beta coefficient of 0.89. Check out the list of the most volatile stocks — is VERTEX PHARMACEUTICAL COM STK USD0.01 there?
0QZU earnings for the last quarter are 4.08 USD per share, whereas the estimation was 3.93 USD resulting in a 3.72% surprise. The estimated earnings for the next quarter are 4.07 USD per share. See more details about VERTEX PHARMACEUTICAL COM STK USD0.01 earnings.
VERTEX PHARMACEUTICAL COM STK USD0.01 revenue for the last quarter amounts to 2.48 B USD despite the estimated figure of 2.50 B USD. In the next quarter revenue is expected to reach 2.51 B USD.
Yes, you can track VERTEX PHARMACEUTICAL COM STK USD0.01 financials in yearly and quarterly reports right on TradingView.
0QZU stock has risen by 2.22% compared to the previous week, the month change is a 3.10% fall, over the last year VERTEX PHARMACEUTICAL COM STK USD0.01 has showed a 22.59% increase.
0QZU net income for the last quarter is 968.80 M USD, while the quarter before that showed 1.04 B USD of net income which accounts for −6.42% change. Track more VERTEX PHARMACEUTICAL COM STK USD0.01 financial stats to get the full picture.
Today VERTEX PHARMACEUTICAL COM STK USD0.01 has the market capitalization of 103.30 B, it has decreased by 1.59% over the last week.
No, 0QZU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0QZU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VERTEX PHARMACEUTICAL COM STK USD0.01 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 5.40 K employees. See our rating of the largest employees — is VERTEX PHARMACEUTICAL COM STK USD0.01 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VERTEX PHARMACEUTICAL COM STK USD0.01 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VERTEX PHARMACEUTICAL COM STK USD0.01 stock shows the buy signal. See more of VERTEX PHARMACEUTICAL COM STK USD0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VERTEX PHARMACEUTICAL COM STK USD0.01 future price: according to them, 0QZU price has a max estimate of 574.00 USD and a min estimate of 325.00 USD. Read a more detailed VERTEX PHARMACEUTICAL COM STK USD0.01 forecast: see what analysts think of VERTEX PHARMACEUTICAL COM STK USD0.01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VERTEX PHARMACEUTICAL COM STK USD0.01 EBITDA is 3.95 B USD, and current EBITDA margin is 45.32%. See more stats in VERTEX PHARMACEUTICAL COM STK USD0.01 financial statements.